Gabriel Cian’s Post

For those interested in the emerging longevity megatrend, check out this group for a flow of investable ideas where the education alone is probably worth your time, and you just might get a chance to be a part of the next big thing.

It’s not about money. It’s about you. Detecting cancer early. Strengthening your heart. Balancing hormones. Waking up with energy. Sleeping with ease. Feeling your best. Being present with people you love. Our investor lineup—technologists, doctors, vc’s, actors, athletes—invested in you. This $53M investment ensures that Function is here for you and the eight billion others who deserve to own their health. Function’s mission is for you to live 100 healthy years. Health always starts as soon as possible. Join Function Health today at functionhealth.com. -- a16z Bio + Health, Mark Hyman, MD, Jay Shetty, K5 Global, Blake Griffin, Amy Griffin, Joel Embiid, Zac Efron, Able Partners, Ara Katz, Colin Kaepernick, Colin O'Brady, Casey Means, MD, Harvey Spevak, Julia Klim, Justin Mares, Marie Forleo, Yung Pueblo, Craig Clemens, Cade Ventures, Fearless Ventures, Pari Passu Venture Partners, Spacecadet, Wisdom Ventures, Jonathan Swerdlin, Pranitha Patil, Mike Nemke, Seth Weisfeld, Vijay Pande, PhD, Daisy Wolf, Zach Cohen, Annie Collins, Bryan Kim

The more we know the more we can make better choices regarding our health.

Entrepreneurs in the longevity landscape 👇👇👇 Benefit from the network of Gabriel to skyrocket your startup project🚀🚀🚀

What is braintech? Why is it an impact topic? What is unique about braintech start-ups? Hear it from Anne-Sophie Saint-Martin at Newfund 💡 Here are some key insights 🧠: - Braintech is a key impact area as 1. the world population grows older, 2. there is a surge in chronic diseases, 3. mental and neurological diseases are the largest group of diseases globally - Compared to cancer or cardiovascular diseases, we are far behind in diagnosing and treating neurological diseases - Europe has approximately the same quantity and quality of braintech start-ups as the USA. However, monetization happens in the USA - they can charge 10x, 20x, 50x the price in the USA - FDA approval is one of the most significant barriers for braintech, so investors are, in general, struggling to price the risk of investing before the approval - Heka counters it with its partnership with the FondaMental Foundation - The largest trend in braintech is techbio, enabling new discoveries Read all about it in Impact Supporters 🔍: https://lnkd.in/gfmbbkEY #impact, #sustainability, #venturecapital, #braintech, #healthtech

‘Aging is solvable’ – longevity film documents battle against human aging New documentary explores the inner workings of the top longevity startups and how they are transforming the landscape of human aging. NFX #investment #economy #aging #documentary #longevity

🌟 Game-Changer Alert! 🌟 When most people think of the American Heart Association (AHA), they picture a nonprofit advocating for heart health, not a powerhouse venture fund reshaping women’s health innovation. But the Go Red for Women Fund is doing just that, tackling an urgent gap in healthcare: women’s cardiovascular, brain, and related health systems. Many might be surprised that a traditionally government-funded agency like the AHA has a venture capital arm, but that’s part of what makes this fund so impactful. By investing directly in early-stage startups focused on women’s cardiovascular and brain health, the AHA is helping advance life-saving innovations that might otherwise struggle to find support. The Go Red for Women Fund strategically backs companies innovating in diagnostics, treatment, and preventative care specifically for women. But it’s not just heart health – They want to fund advancements in preventing heart disease, stroke, kidney and metabolic conditions, mental health, and Alzheimer’s/dementia. The fund has also identified opportunities in funding advancements for conditions with strong cardiovascular impacts, to include menopause, autoimmune disease, or PCOS. This approach amplifies AHA’s mission far beyond what traditional grants could achieve. These investments bring women’s health solutions to the forefront, closing gaps in healthcare outcomes by fueling advancements that prioritize women’s unique health needs. AHA is turning dollars into results, championing founders who are boldly redefining women’s cardiovascular and brain health. If you’re a startup with a vision for women’s health, AHA’s Go Red for Women Fund is the partner you want on your radar! #GoRedForWomen #WomensHealth #HeartHealth #WomenInHealth #MindtheGapServices

The tide is turning for Alzheimer’s patients and those who love them. Thank you StartUp Health for the work you do to keep focus on this important fight. Learn more about how ALZpath Inc. is joining the battle in the article below and at www.ALZpath.bio

The burden of Alzheimer's disease and related dementias may seem daunting. However, we are pleased to have thought leaders and Health Moonshot Community partners like StartUp Health who are in this fight with us. In a recent interview, our CEO, Chad Holland, shared some perspective on how ALZpath is purpose built to bring p-Tau217 testing to dramatically more of the patients that need it. However, whether it be through partnerships, like the one we recently signed with Roche, or further innovations guided by our outstanding founder team, ALZpath is not going to limit itself to p-tau217. "We're not just going to be a p-tau217 company going forward", says Holland. "I think we're just at this early part of the convergence of neuroscience and medicine and drug development". 📌 Find out more about ALZpath's origins, current on market success and future plans by visiting www.ALZpath.bio 📌 Read the full story by StartUp Health here: https://lnkd.in/g7WjpgAs #pTau217 #Alzheimers #HealthCareInnovation #Diagnostics #Biotechnology #BrainHealth #ALZpath Alzheimer's Association®, Alzheimer's Society, Alzheimer's Foundation of America, Dementia Alliance International, UsAgainstAlzheimer's, Alzheimer's Research UK, Cure Alzheimer's Fund, BrightFocus Foundation

"After breakthroughs in cancer, rare diseases, metabolic, what's next?" Lord David Prior of Brampton asked Jane Osbourn OBE, Dr. Matthias Müllenbeck, MBA, Joep Muijrers, and Tamsin Berry "Watch what's about to happen in neurology." "Watch for the blurring between consumer health and wellness and traditional therapeutics." Some other take-aways from a fascinating discussion from the Panel on the future of innovation in population health yesterday at The Galien Foundation's #PrixGalien forum in London: On #LifeScience #investment: In these times of #marketaccess uncertainty, Investors are taking access pathways into account for their decisions from the earliest stages. Also: "Biotechs go where the money is. We need more biotech investment from UK and EU pension funds to build innovation here in Europe." From Tamsin on the seismic shifts in #publichealth driven by biotech innovation: "When working in public health earlier in my career it was 'eat less, drink better, run around the block' It's exciting to see a combination of behavior innovations and therapeutics that give us more tools to manage health."